Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
Top Cited Papers
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 359 (9315) , 1388-1392
- https://doi.org/10.1016/s0140-6736(02)08352-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- Surgeons’ assessment of symptoms suggesting extrathoracic metastases in patients with lung cancerThe Annals of Thoracic Surgery, 1999
- FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?European Journal of Nuclear Medicine and Molecular Imaging, 1998
- Pretreatment Evaluation of Non–Small-cell Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Management of lung cancer in South East Scotland.Thorax, 1996
- Staging non—small cell lung cancer by whole-body positron emission tomographic imagingThe Annals of Thoracic Surgery, 1995
- Investigation for mediastinal disease in patients with apparently operable lung cancerThe Annals of Thoracic Surgery, 1995
- Pretreatment minimal staging for non-small cell lung cancer: an updated consensus reportLung Cancer, 1994
- Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancerThe Lancet, 1994
- Evaluating and comparing imaging techniques: a review and classification of study designsThe British Journal of Radiology, 1987